Медицина/7.Клиническая медицина
PhD. Olenovych O.A.
Bukovinian State Medical
University, Chernivtsy
NONSPECIFIC BODY REACTIVITY IN PATIENTS WITH DIABETES MELLITUS DEPENDING ON
ITS DURATION
Introduction. Diabetes mellitus (DM) – is the most widespread form
of the disturbance of all types of metabolism. As it is well known, body
metabolic processes are significantly changed in case of DM, influencing on
adaptive body potential and the degree of its immune reactivity [4]. Investigation of
the adaptive body reserves, starting mechanisms of dysadaptation processes is
of a high importance in relation to DM, known to be accompanied by the
significant disturbances of natural and acquired immunity [2], serious
disorders of neuroendocrine and immune interaction [7], that stipulates the
severity and prognosis of the disease. That’s why the comparative analysis of
immune reactivity parameters in DM of various duration is of a special
attention in concern of their timely correction and prognosis of the probable
individual patient’s response on administered treatment.
Considering that, the objective of this research was to study the changes of reactivity
and adaptive body potential in patients with diabetes mellitus depending on its
duration.
Materials and methodology.
33
patients with DM (17 men and 16 women – 52 and 48% respectively), aged between
19 and 78 years (mean age – 50,70±2,27 years) and 10 healthy individuals, who served as control
group, participated in the study. The verification of the diagnosis was based on
thorough clinical-anamnestic and laboratory-instrumental investigations
according to the WHO recommendations.
According to the results of complex patients’
examination DM type 1 was established in 10 patients – 30% (mean age – 36,50±3,83 years), whereas in
23 patients (70%) DM type 2 was diagnosed (mean age – 56,87±1,55 years). The
severity of the disease was assessed by the degree of clinical symptoms manifestation.
Thus, moderate severity of DM was identified in 17 enrolled patients with
overwhelming majority of DM type 2 patients (82%); severe form of the disease
was observed in 16 examined patients, represented by 44% of type 1 diabetics
and 56% of type 2 diabetics; individuals with mild diabetes were absent among
those involved into the study. All participating patients were at the
subcompensation stage of the disease.
In 12 of enrolled patients (group 1) the duration of diabetes was less
than 5 years (3,38±0,56 years), in 11 participating individuals (group 2) diabetes
lasted for 6-10 years (7,82±0,56 years), 10 of participants (group 3) had diabetes
longer than 10 years (15,10±1,11 years). It should be noted, that the cohort of
patients with DM type 1 in severe form was equally represented by cases of its
duration less than 5 and more than 10 years, whereas in patients with DM type 2
severe form of the disease was mostly observed at the duration more than 10
years.
Integral haematological coefficients were used for the
assessment of adaptive potential and general reactivity in diabetic patients [1, 9]: leukocytic index
(LI), modified leukocytic
intoxication index by B.A.Reys (LII), leukocyte shift index (LSI), neutrophils to
lymphocytes ratio index (NLRI), leukocytes to sedimentation ratio index (LSRI), lymphocytic-granulocytic index
(LGI), nuclear intoxication index (NII), neutrophils to monocytes ratio index (NMRI).
Statistical processing of the obtained data was performed by means of «Biostat»
software, using paired Student’s t-criterion.
Results and discussion. Integral haematological
indices calculation revealed substantial changes of nonspecific resistance
indices in patients with diabetes depending on its duration. Thus, the decline
of LI was found to be inversely proportional to the duration of
diabetes and reliably significant at its duration over than 6 years (by 26,9% concerning controls, P<0,001), practically
further unchanging (remaining by 23,1% lower at the duration of DM longer than 10 years as
compared with that in controls, P<0,001, P2>0,1). The decrease of NMRI had the same tendency with its
unreliable elevation at diabetes duration over than 10 years (P>0,5). Meantime, other nonspecific
resistance index – NLRI – enhanced proportionally to diabetes duration, ranking
maximal level in patients with 6-10 years DM duration, remaining high at longer
duration of the disease (NLRI increased by 31,1 and 28,4% in patients of group 2 and
group 3 respectively, P<0,001, P2>0,5).
Table. Integral haematological indices in patients
with diabetes mellitus depending on its duration (Х±Sx)
|
Indices |
Group, number of examined
patients |
|||
|
Healthy individuals, n=10 |
Patients with DM, duration less than 5 years, group 1, n=12 |
Patients with DM, duration 6-10 years, group 2, n=11 |
Patients with DM, duration over than 10 years, group 3, n=10 |
|
|
Leukocytic index (LI) |
0,52±0,02 |
0,44±0,04 Р>0,1 |
0,38±0,01 Р<0,001 P1>0,1 |
0,40±0,01 Р<0,001 P1>0,3 P2>0,1 |
|
Leukocytic intoxication index (LII) |
1,70±0,05 |
2,02±0,13 Р<0,05 |
2,14±0,07 Р<0,001 P1>0,5 |
2,11±0,06 Р<0,001 P1>0,5 P2>0,7 |
|
Leukocyte shift index (LSI) |
1,84±0,05 |
2,12±0,14 Р>0,09 |
2,24±0,06 Р<0,001 P1>0,4 |
2,24±0,05 Р<0,001 P1>0,4 P2=1,0 |
|
Leukocytes to sedimentation ratio index (LSRI) |
1,85±0,20 |
0,97±0,11 Р<0,001 |
1,54±0,28 Р>0,3 P1>0,06 |
1,95±0,39 Р>0,8 P1<0,02 P2>0,3 |
|
Lymphocytic-granulocytic index (LGI) |
4,38±0,15 |
3,86±0,31 Р>0,1 |
3,35±0,10 Р<0,001 P1>0,1 |
3,43±0,10 Р<0,001 P1>0,2 P2>0,5 |
|
Nuclear intoxication index (NII) |
0,17±0,02 |
0,12±0,01 P<0,05 |
0,13±0,01 P>0,08 P1>0,4 |
0,14±0,01 P>0,1 P1>0,1 P2>0,4 |
|
Neutrophils to lymphocytes ratio index (NLRI) |
2,08±0,07 |
2,51±0,17 Р<0,05 |
2,73±0,08 Р<0,001 P1>0,2 |
2,67±0,07 Р<0,001 P1>0,4 P2>0,5 |
|
Neutrophils to monocytes ratio index (NMRI) |
13,54±0,96 |
12,96±0,87 P>0,6 |
11,83±0,72 P>0,1 P1>0,3 |
17,06±5,25 P>0,5 P1>0,4 P2>0,3 |
Note: values are expressed as means ± standard
errors; number of patients in a group; Р – significant difference in comparison
with healthy individuals; Р1 – significant difference in comparison with
patients of group 1; Р2 – significant difference in
comparison with patients of group 2.
These findings evidence the impairment of
nonspecific immune resistance (contributed mostly by microphages at DM duration
for 6-10 years and macrophages – at its duration over than 10 years), as well
as specific immune responsiveness, reliably significant already after 6th
year of the disease.
Disturbance of the resistance,
in its turn, determines the intensity and gravity of endogenous intoxication.
Thereby, the signs of intoxication according to LII were found even in patients
with non-protracted DM (LII exceeded control index by 18,8%, P<0,05, in patients of group 1), enhancing with its duration (LII
was found to be elevated by 29,9 and 24,1% in patients of group 2 and group 3 respectively,
P<0,001). LSI was also higher
than of control by 14,6% (P>0,09) in case of
diabetes duration less than 5 years and by 21,7% – in case of protracted
diabetes (P<0,001, P2=1,0).
The reduction of inflammation
index LGI was found to be reliable in patients with DM duration for 6-10 years
as compared with that in controls, continuing to remain lowered (LGI was by
23,5 and 21,7% lower than in controls in patients of group 2 and group 3 respectively,
P<0,001, P2>0,5). At the same time,
inflammation index LSRI, maximally low in patients with DM duration for less
than 5 years (by 1,9 times less than control level, P<0,001), tended to the
increase proportionally to the duration of the disease, being twice higher in patients
of group 3 (P1<0,02).
Such changes of the studied
parameters allow to suggest, that intoxication accompanying diabetes is
endogenous, develops at the beginning of the disease and is caused, probably,
by activation of the destructive mechanisms of tissue decomposition due to
diabetes-associated dysmetabolic processes [3, 11]. On the background of absent
neutralizing opposition by detoxicating systems of the body, whose
decompensation is evidenced by decreased NII in case of DM of various duration,
and insufficient fermentative systems, dramatically disturbed in case of
diabetes, autointoxication leads to the development of «metabolic immune
defect», resulting in dysregulation of immunopoiesis, proliferation and
metabolism of immunocompetent cells, autoregulation of immune response [8].
The accumulation of
unphysiologic concentrations of intermediate and end products of metabolism,
oxygen deficiency and oxidative tissues destruction, cellular stress mediators,
other endotoxins, causative for toxemia [3], are found to be proportional to the duration of the
disease. This explains more considerable autointoxication in patients with DM longer
than 10 years, and, predictably, overexertion and exhaustion of macrophagic
immune reactivity, directed mostly towards various products of tissue
destruction [5].
Monocytic dysfunction, as well as inhibition of microphagic immune reactivity
in patients with DM duration for 6-10 years, in its turn, provokes the
disturbance of antigen presentation to immunocompetent cells, resulting in
distortion of specific immunity [12].
Conclusions:
1) Dynamics of changes of
integral haematological coefficients in case of diabetes mellitus is indicative
for the development of endogenous intoxication, whose intensity enhances
proportionally to the duration of the disease and is considered not only as the
consequence of metabolism disturbances, typical for diabetes, but as the cause of
pathological reactions as well, modulating the influence on body immunological reactivity
and immune system disorganization in particular.
2) In case of diabetes
mellitus the impairment of specific immunity as well as nonspecific one is
formed, leading to dysregulation of cell-mediated and humoral reactions and
depending on diabetes duration: at DM duration for 6-10 years the reduction of
immune resistance is mostly contributed by macrophages, accompanied in the
future by monocytic dysfunction on the background of significant deficiency of
specific immune defense.
REFERENCES:
1.
Клініко-лабораторні показники у хворих на інфекційний
мононуклеоз різної етіології / В.М.Козько, О.І.Могиленець, Н.Ф.Меркулова [та
ін.] // Інфекційні хвороби. – 2012. – № 4 (70). – С.35–37.
2.
Особливості імунного статусу хворих на цукровий діабет
типу 1 / О.А.Оленович, Н.В.Пашковська, Л.Б.Павлович [та ін.]: матеріали
наук.-практ. Інтернет-конф. з міжнар. уч. [«Цукровий діабет – міждисциплінарна
проблема сучасної медицини»], Чернівці, 10-12 червня 2013р.: тези доп. –
Чернівці: БДМУ, 2013. – С.59–60.
3. Ведунова М.В. Уровень эндогенной
интоксикации при метаболическом синдроме / М.В.Ведунова, К.Н.Конторщикова,
Н.А.Дороротина // Вестн.
Нижегород.
ун-та им.Н.И.
Лобачевского. – 2008.
– №2. – С.87–90.
4.
Гаркави
Л.Х. Понятие здоровья с позиции теории неспецифических адаптационных реакций организма / Л.Х.Гаркави, Е.Б.Квакина
// Валеология. – 1996. – № 2. – С.15–20.
5. Дранник
Г.Н. Клиническая иммунология и аллергология : пособ. [для студ.,
врач.-интер., иммун., аллергол., врач. леч. профиля всех спец.] / Г.Н.Дранник.
– К., 2010. – 552с.
6. Железнякова Н.М. Пути формирования синдрома
эндогенной интоксикации у больных
с коморбидным течением ХОЗЛ и хронического панкреатита / Н.М.Железнякова // Вісн. пробл. біол. і мед. – 2011. – №4. – С.89–91.
7. Изучение адаптационных механизмов и
коррекция их нарушений у детей и подростков с сахарным диабетом 1-го типа / Н.В.Николаева, Н.В.Болотова,
В.Ф.Киричук [и др.] // Педиатрия. – 2009. – Т.88, №6. –
С.21-26.
8. Лейдерман И.Н. Синдром полиорганной недостаточности. Метаболические основы / И.Н.Лейдерман
// Вестн. интенсив. терапии. – 2009. – №2. – С.34–39.
9. Показатели
крови и лейкоцитарного индекса интоксикации в оценке тяжести и определении
прогноза при воспалительных, гнойных и гнойно-деструктивных заболеваниях /
В.К.Островский, А.В.Мащенко, Д.В.Янголенко [та ін.] // Клин. лаб. диагност. – 2006. – №6. –
С.50–53.
10.
Рейс Б.А. Выделение токсического полипептида средней
молекулярной массы при экспериментальном разлитом перитоните / Б.А.Рейс, Л.В.Полуэктов
// Бюл. эксперим. биол. и мед. – 1983. – №7. – С.53–55.
11. Сперанский В.В. Иммунологическая информативность
лейкоцитограммы / В.В.Сперанский, И.И.Дмитриева, Р.М.Зарипова //
Клин. лаб. диагност. – 1999. – №12. – С.6–7.
12. Шано В.П. Синдром эндогенной интоксикации
/ В.П.Шано, Е.А.Кучер // Острые и неотложные состояния в практике врача. –
2011. – №1 (25). –
С.35–41.